基于多步虚拟查和分子动力学模拟的强有力的USP5抑制剂的计算洞察力
Qian Xie1, Linan Zhao1, Dong Hu2
1Chongqing University Qianjiang Hospital (Qianjiang Central Hospital of Chongqing), Chongqing, China.
Journal of receptor and signal transduction research
|December 20, 2024
概括
研究人员确定了三种新型化合物 (CHEMBL3645368,CHEMBL3689818和CHEMBL2070208),这些化合物显示出潜在的USP5抑制剂,USP5是一种涉及瘤进展的蛋白质. 这些化合物表现出有希望的结合亲和力和低毒性,需要进一步研究作为癌症治疗药物.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 计算化学计算化学
背景情况:
- 乌比基特异蛋白酶5 (USP5) 经常在恶性瘤中发现.
- USP5在稳定促进瘤进展的蛋白质方面发挥作用.
- 需要强大的USP5抑制剂来向癌症的发展.
研究的目的:
- 选和识别USP5.5的新型有效抑制剂.
- 评估已识别的化合物作为抗癌剂的潜力.
主要方法:
- 在TCMIO数据库中选潜在的USP5抑制剂.
- 使用分子对接,分子指纹分析,量子化学和分子动力学模拟.
- 评估结合亲和力,分子相互作用和ADMET特性.
主要成果:
- 已经确定了三种被击中化合物 (CHEMBL3645368,CHEMBL3689818和CHEMBL2070208).
- 这些化合物表现出与积极对照相似的结合模式.
- 计算分析表明,与积极对照相比,结合能量和亲和力更强.
- 预测的ADMET概况表明,对于已识别的化合物,毒性较低.
结论:
- CHEMBL3645368,CHEMBL3689818和CHEMBL2070208显示出抑制USP5.5的显著潜力.
- 这些化合物代表了进一步临床前开发的有希望的候选人,作为针对USP5.5的抗癌药物.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
371
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
4.9K
相关概念视频
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Structure-Activity Relationships and Drug Design
510
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
510
